Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of "Hold" from Analysts

Key Points

• Analysts maintain a “Hold” consensus on Acadia Healthcare, with 7 buy ratings, 5 holds, 2 sells and 1 strong buy. The average 12-month price target is approximately $29.85.
• Acadia reported quarterly EPS of $0.38, beating estimates of $0.35, while revenue reached $865.84 million and declined slightly year over year. The company issued fiscal 2026 EPS guidance of $1.45–$1.60.
• The stock opened at $27.46 after falling 8.5%; meanwhile, major institutional investors—including BlackRock, Goldman Sachs and Jefferies—recently established or expanded positions.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) have earned a consensus rating of "Hold" from the fifteen analysts that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $29.8462.

A number of analysts recently issued reports on the company. UBS Group upped their target price on Acadia Healthcare from $31.00 to $39.00 and gave the company a "buy" rating in a research report on Thursday, July 9th. Royal Bank Of Canada boosted their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the company an "outperform" rating in a research note on Monday, May 4th. Cantor Fitzgerald reissued a "neutral" rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. TD Cowen lifted their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Finally, Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a research report on Friday, June 12th.

Acadia Healthcare Trading Down 8.5%

NASDAQ ACHC opened at $27.46 on Wednesday. Acadia Healthcare has a 12 month low of $11.43 and a 12 month high of $35.83. The company has a market capitalization of $2.56 billion, a price-to-earnings ratio of -2.21, a price-to-earnings-growth ratio of 9.98 and a beta of 0.64. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. The firm's fifty day moving average price is $29.79 and its 200 day moving average price is $25.29.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. During the same quarter in the prior year, the firm posted $0.83 earnings per share. Acadia Healthcare's revenue for the quarter was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, sell-side analysts expect that Acadia Healthcare will post 1.54 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds have recently made changes to their positions in the business. BlackRock Inc. purchased a new stake in shares of Acadia Healthcare during the second quarter worth approximately $441,685,000. Goldman Sachs Group Inc. boosted its holdings in Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company's stock worth $67,099,000 after buying an additional 3,815,471 shares in the last quarter. Jefferies Financial Group Inc. acquired a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $106,458,000. Wellington Management Group LLP grew its holdings in Acadia Healthcare by 24.9% in the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company's stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Finally, Vaughan Nelson Investment Management L.P. acquired a new stake in Acadia Healthcare in the 1st quarter valued at about $43,017,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source